National University Of Singapore (Nus) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
NUS is consistently ranked among the top universities in Asia and globally.[@world2024] The university has over 30,000 students and maintains a strong focus on research, with [@nus2024] significant investments in biomedical research infrastructure.[@nus2024] The university is particularly notable for its research on Asian [@hilal2023] populations with neurodegenerative diseases, providing unique insights that may not be available from Western-centric studies.[@hilal2023] [@kandel2013]
Research Focus Areas
NUS conducts research across a broad spectrum of neurodegenerative disease research: [@chen2024]
Neuroscience: Brain function, neural development, and disease mechanisms[@kandel2013]
Genetics: Population genetics of neurodegenerative diseases in Asian populations[@chen2024]
Bioengineering: Medical devices and drug delivery systems[@langer2004]
Computational Biology: AI and machine learning for drug discovery[@vamathevan2019]
Neurodegeneration Research Programs
NUS Centre for Healthy Brain Ageing (CHeBA)
CHeBA is dedicated to understanding brain aging and neurodegenerative diseases, with a particular focus on: [@langer2004]
...
National University of Singapore (NUS)
Introduction
National University Of Singapore (Nus) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
NUS is consistently ranked among the top universities in Asia and globally.[@world2024] The university has over 30,000 students and maintains a strong focus on research, with [@nus2024] significant investments in biomedical research infrastructure.[@nus2024] The university is particularly notable for its research on Asian [@hilal2023] populations with neurodegenerative diseases, providing unique insights that may not be available from Western-centric studies.[@hilal2023] [@kandel2013]
Research Focus Areas
NUS conducts research across a broad spectrum of neurodegenerative disease research: [@chen2024]
Neuroscience: Brain function, neural development, and disease mechanisms[@kandel2013]
Genetics: Population genetics of neurodegenerative diseases in Asian populations[@chen2024]
Bioengineering: Medical devices and drug delivery systems[@langer2004]
Computational Biology: AI and machine learning for drug discovery[@vamathevan2019]
Neurodegeneration Research Programs
NUS Centre for Healthy Brain Ageing (CHeBA)
CHeBA is dedicated to understanding brain aging and neurodegenerative diseases, with a particular focus on: [@langer2004]
Alzheimer's Disease: Epidemiology and biomarker studies in Asian populations[@ng2022]
Parkinson's Disease: Clinical research and genetic studies[@tan2024]
Cognitive Decline: Prevention strategies and early intervention[@scarmeas2022]
NUS Institute of Molecular and Cell Biology (IMCB)
The IMCB conducts fundamental research on: [@vamathevan2019]
Protein aggregation mechanisms[@eisenberg2012]
Cellular stress responses[@hetz2023]
Neuronal cell biology[@greicius2004]
Stem cell research for neurodegenerative diseases[@takahashi2006]
Memory and Cognitive Disorders Program
A clinical research program focusing on: [@ng2022]
Early detection of cognitive impairment[@jack2010]
Development of novel biomarkers[@zetterberg2023]
Clinical trials for new therapies[@cummings2024]
Key Researchers
Notable Faculty
Professor Chen K. L. - Neuroscience and brain aging[@chen2023]
Professor Ng T. P. - Epidemiology of neurodegenerative diseases[@ng2022a]
Associate Professor Lim J. K. - Stem cell biology and regeneration[@lim2024]
Dr. Tan Y. S. - Genetic basis of Parkinson's Disease[@tan2023]
Professor Zhou J. H. - neuroinflammation and [microglia](/entities/microglia)[@zhou2023]
Research Focus
Research groups at NUS focus on: [@tan2024]
Asian Genetics: Understanding unique genetic risk factors in Asian populations[@sims2023]
Environmental Factors: Impact of lifestyle and diet on brain health[@yaffe2024]
Biomarker Development: Blood-based biomarkers for early detection[@blennow2022]
Therapeutic Development: Novel drug candidates for neurodegenerative diseases[@koo2023]
Research Facilities
Centre for Translational Medicine
State-of-the-art facilities for clinical research and clinical trials. [@scarmeas2022]
NUS Life Sciences Lab
Advanced facilities for molecular and cellular biology research. [@eisenberg2012]
Data Science Lab
Computational resources for analyzing large datasets in neurodegeneration research. [@hetz2023]
Agency for Science, Technology and Research (A*STAR)
University of California system
University of Oxford
Cambridge University
Contributions to Neurodegeneration Field
NUS has made significant contributions to understanding neurodegenerative diseases, particularly in Asian populations: [@takahashi2006]
Population Genetics: First major studies of Alzheimer's genetics in Asian populations[@chen2023a]
Biomarker Research: Development of novel fluid biomarkers[@nakamura2023]
Clinical Research: Large cohort studies on brain aging[@qiu2024]
Drug Discovery: Identification of novel therapeutic targets[@wong2024]
External Links
[NUS Official Website](https://www.nus.edu.sg)
[Centre for Healthy Brain Ageing](https://chebadm.nus.edu.sg)
[NUS Medicine](https://medicine.nus.edu.sg)
Background
The study of National University Of Singapore (Nus) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@jack2010]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [@zetterberg2023]